References

1. Spruance SL et al. Antimicrob Agents Chemother 2002; 46:2238–2243.
2. Trottet L et al. Int J Pharm 2005; 304:63–71.
3. Hull CM. J Am Acad Dermatol 2011; 64:696.e1–e11.
4. Strand A. Pediatr Dermatol 2012; 29:105–110.
5. Hollmen KA et al. J Eur Acad Dermatol Venereol 2002; 16:87–88.
6. van Heerden JS, Vismer HF. Dermatology 1997; 194:14–18.
7. Ortonne JP et al. J Eur Acad Dermatol Venereol 2006; 20:1307–1313.
8. Li RY et al. Clin Drug Investig 2014; 34:223–230.
9. de Chauvin MF et al. Mycoses 2007; 51:1–6.
10. Kienzler JL et al. Curr Med Res Opin 2007; 23:1293–1302.
11. Korting HC et al. Med Mycol 2001; 39:335–340.
12. Budimulja U et al. Mycoses 2001; 44:300–306.
13. Budimulja U et al. Int J Dermatol1998; 37:870–873.
14. Hill S et al. Br J Dermatol 1992; 127:396–400.